Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 3/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 2/20 | 1.00 |
| ▸ | MAOB | P27338 | 2/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 1/20 | 1.00 |
| ▸ | GLO1 | Q04760 | 1/20 | 1.00 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 1.00 |
| ▸ | BACE1 | P56817 | 12/20 | 0.73 |
| ▸ | TYR | P14679 | 3/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | F3 | P13726 | 1/20 | 0.68 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.68 |
| ▸ | CA12 | O43570 | 2/20 | 0.65 |
| ▸ | CA1 | P00915 | 2/20 | 0.65 |
| ▸ | CA2 | P00918 | 2/20 | 0.65 |
| ▸ | CA7 | P43166 | 2/20 | 0.65 |
| ▸ | CA9 | Q16790 | 2/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.65 |
| ▸ | ESR1 | P03372 | 1/20 | 0.65 |
| ▸ | CA3 | P07451 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bisdemethoxycurcumin SCHEMBL2574140 | 1.00 | AKR1B1 (1.00) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| Bisdemethoxycurcumin SCHEMBL28163045 | 0.98 | AKR1B1 (0.96) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL16702807 | 0.92 | AKR1B1 (0.85) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL16702808 | 0.92 | AKR1B1 (0.85) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL23728364 | 0.90 | AKR1B1 (0.81) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL12469737 | 0.90 | AKR1B1 (0.81) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL3221765 | 0.90 | AKR1B1 (0.81) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL1646483 | 0.90 | AKR1B1 (0.81) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL12469736 | 0.90 | AKR1B1 (0.81) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL3211832 | 0.90 | MAOB (0.81) | AKR1B1AKR1B10MAOBPTGS2GLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 705 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3829555-B1 | COMPOSITIONS COMPRISING RESVERATROLOSIDES AND CURCUMIN | RAVAGNAN GIAMPIETRO (IT) | 2026-05-13 | — | — | EP | claimed |
| US-12601970-B2 | Photosensitive resin composition, method for manufacturing patterned cured product, cured product, interlayer insulating film, cover coat layer, surface protective film, and electronic component | HD MICROSYSTEMS, LTD. (JP) | 2026-04-14 | — | — | US | claimed |
| EP-4633619-A1 | FORMULATION COMPRISING VANILLOID POLYPHENOLS SUPPORTED ON LAMELLAR SOLIDS TO REDUCE PLASMA CGRP LEVELS AND ITS APPLICATIONS | Prolabin & Tefarm S.R.L. (IT) | 2025-10-22 | — | — | EP | claimed |
| US-12419930-B2 | Bioavailable turmeric composition and process for preparation thereof | OLENE LIFE SCIENCES PRIVATE LIMITED (IN) | 2025-09-23 | — | — | US | claimed |
| US-20250262155-A1 | LITHE LIPOSOMES COMPRISING ABSORPTION ENHANCERS FOR ORAL DRUG DELIVERY | Aspire LLC (US) | 2025-08-21 | — | — | US | claimed |
| US-20250206788-A1 | CURCUMIN-PEPTIDE CONJUGATES AND FORMULATIONS THEREOF | CHANCEY, John (US) | 2025-06-26 | — | — | US | claimed |
| EP-3928000-B1 | DIFFERENTIAL WITH BI-DIRECTIONAL OVERRUNNING CLUTCH | TEAM IND INC (US) | 2025-06-18 | — | — | EP | claimed |
| US-20250127731-A1 | COMPOSITIONS COMPRISING CURCUMINOIDS FOR USE IN THE TREATMENT OF MUSCLE SORENESS | GIVAUDAN SA (CH) | 2025-04-24 | — | — | US | claimed |
| US-12247054-B2 | Curcumin-peptide conjugates and formulations thereof | HAUS BIOCEUTICALS, INC. | 2025-03-11 | — | — | US | claimed |
| WO-2024250032-A9 | SOLUBLE CURCUMIN AND ITS DERIVATIVES | THERMOLIFE INTERNATIONAL, LLC (US) | 2025-03-06 | — | — | WO | claimed |
| CN-104116731-A | Pharmaceutical composition for preventing arteriosclerosis and preparation method thereof | GUANGDONG MEDICAL COLLEGE | 2014-10-29 | — | — | CN | claimed |
| CN-103800390-A | Health-care product with immunity-reinforcing and liver-protecting functions, preparation method and application thereof | TIANJIN TROPJOIN HEALTH TECHNOLOGY GROUP CO LTD | 2014-05-21 | — | — | CN | claimed |
| US-20130316029-A1 | METHODS AND COMPOSITIONS SUITABLE FOR MANAGING BLOOD GLUCOSE IN ANIMALS | NESTEC S.A. (CH) | 2013-11-28 | — | — | US | claimed |
| US-20130209583-A1 | METHODS AND COMPOSITIONS SUITABLE FOR PROMOTING HEALTHY SKIN | NESTEC S.A. (CH) | 2013-08-15 | — | — | US | claimed |
| US-20100105644-A1 | BOTANICAL COMPOSITION FOR ENHANCED SKIN REPAIR AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-04-29 | — | — | US | claimed |
| US-20090000734-A1 | Method For Producing a Cladding Element | INTERGLARION LIMITED (CY) | 2009-01-01 | — | — | US | claimed |
| EP-1978984-A2 | NUTRITIONAL SYSTEM AND METHODS FOR INCREASING LONGEVITY | NESTEC S.A. (CH) | 2008-10-15 | — | — | EP | claimed |
| US-20070231371-A1 | Nutritional system and methods for increasing longevity | NESTEC, S. A. | 2007-10-04 | — | — | US | claimed |
| WO-2007088046-A2 | NUTRITIONAL SYSTEM AND METHODS FOR INCREASING LONGEVITY | NESTEC S.A. (CH) | 2007-08-09 | — | — | WO | claimed |
| US-20030082116-A1 | Adhesive compositions containing dual function stabilizers and active agents | CLOSURE MEDICAL CORPORATION (US) | 2003-05-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12601970-B2 | Photosensitive resin composition, method for manufacturing patterned cured product, cured product, interlayer insulating film, cover coat layer, surface protective film, and electronic component | ARCN1, P4HA1, COL1A1 | AKR1B1 1232/4885AKR1B10 1091/4885MAOB 1852/4885 |
| US-20070231371-A1 | Nutritional system and methods for increasing longevity | AGER, GCKR, IGFBP1 | AKR1B1 869/4885AKR1B10 1332/4885MAOB 3559/4885 |
| US-20100105644-A1 | BOTANICAL COMPOSITION FOR ENHANCED SKIN REPAIR AND USES THEREOF | CUTA, COL14A1, BACH1 | AKR1B1 1088/4885AKR1B10 916/4885MAOB 1308/4885 |
| US-20030082116-A1 | Adhesive compositions containing dual function stabilizers and active agents | TLN1, PTK2, ILK | AKR1B1 4152/4885AKR1B10 3335/4885MAOB 2491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.